Q3 2024 Earnings Estimate for Exponent, Inc. (NASDAQ:EXPO) Issued By William Blair

Exponent, Inc. (NASDAQ:EXPO) – Investment analysts at William Blair cut their Q3 2024 EPS estimates for Exponent in a report issued on Friday, April 26th. William Blair analyst A. Nicholas now forecasts that the business services provider will post earnings per share of $0.42 for the quarter, down from their prior estimate of $0.44. The consensus estimate for Exponent’s current full-year earnings is $1.76 per share. William Blair also issued estimates for Exponent’s Q4 2024 earnings at $0.40 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.48 EPS, Q4 2025 earnings at $0.47 EPS and FY2025 earnings at $2.04 EPS.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. The company had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The firm’s revenue was up 6.6% compared to the same quarter last year. During the same period last year, the business posted $0.56 earnings per share.

Several other equities analysts also recently issued reports on EXPO. Truist Financial upped their target price on Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Monday. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th.

Exponent Trading Down 2.1 %

Shares of Exponent stock opened at $93.20 on Monday. Exponent has a 12-month low of $64.61 and a 12-month high of $102.72. The firm’s 50 day simple moving average is $80.23 and its two-hundred day simple moving average is $81.85. The firm has a market capitalization of $4.72 billion, a price-to-earnings ratio of 47.07 and a beta of 0.68.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 1.20%. The ex-dividend date is Friday, June 7th. Exponent’s dividend payout ratio is currently 56.57%.

Insiders Place Their Bets

In related news, insider Eric Guyer sold 3,367 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $78.49, for a total transaction of $264,275.83. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by insiders.

Institutional Trading of Exponent

A number of hedge funds have recently added to or reduced their stakes in EXPO. Vanguard Group Inc. increased its position in shares of Exponent by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 4,995,605 shares of the business services provider’s stock valued at $439,813,000 after buying an additional 19,795 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its holdings in Exponent by 9.5% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,685,472 shares of the business services provider’s stock worth $401,076,000 after acquiring an additional 408,295 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in Exponent by 9.6% during the first quarter. Conestoga Capital Advisors LLC now owns 2,687,351 shares of the business services provider’s stock worth $222,217,000 after acquiring an additional 236,050 shares during the period. Geneva Capital Management LLC lifted its holdings in Exponent by 10.4% during the fourth quarter. Geneva Capital Management LLC now owns 1,558,189 shares of the business services provider’s stock valued at $137,183,000 after purchasing an additional 146,778 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of Exponent by 11.4% in the third quarter. Ameriprise Financial Inc. now owns 693,259 shares of the business services provider’s stock valued at $59,343,000 after purchasing an additional 71,074 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.